Overall, this study suggests that Parp-1 rather than Parp-2 inhibition seems to exert more beneficial effects on muscle-related miRs expression of cachectic limb muscles in this specific mouse model of lung cancer cachexia [23]. The gene discussed is PARP1; the disease is lung cancer.